Goldman Sachs
DSCI

Goldman Sachs’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Goldman Sachs’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-10,000
Closed -$116K – 7534
2014
Q2 		$116K Buy
+10,000
New +$103K ﹤0.01% 6496

Other funds holding DSCI

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Goldman Sachs's DSCI Position: Q1 2017 in Review

Goldman Sachs sold out of Derma Sciences, Inc. Common Stock (DE) (DSCI) in Q1 2017, closing a stake of 54,236 shares — an estimated $282K sold.

Goldman Sachs first reported a position in DSCI in Q2 2014 and held it in 11 quarters. The position peaked at $1.52M in Q2 2015. 1 fund tracked by Wall St. Rank holds DSCI as of Q1 2017.

  • Goldman Sachs reported no remaining Derma Sciences, Inc. Common Stock (DE) position as of Q1 2017 after selling out during the quarter.
  • Goldman Sachs sold 54,236 Derma Sciences, Inc. Common Stock (DE) shares in Q1 2017, an estimated $282K.
  • Goldman Sachs first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2014 and held it in 11 quarters.
  • Goldman Sachs's Derma Sciences, Inc. Common Stock (DE) position peaked at $1.52M in Q2 2015.
  • 1 fund tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q1 2017.

Based on Goldman Sachs's 13F filing for Q1 2017, filed 15 May 2017.